|
Session Title: Evaluation of the Centers for Disease Control and Prevention's (CDC's) HIV Prevention Program: Rationale, Reporting, and Realities
|
|
Panel Session 384 to be held in Sebastian Section I1 on Thursday, Nov 12, 4:30 PM to 6:00 PM
|
|
Sponsored by the Government Evaluation TIG
and the Health Evaluation TIG
|
| Chair(s): |
| Dale Stratford, Centers for Disease Control and Prevention, bbs8@cdc.gov
|
| Abstract:
CDC funds 59 state and local health departments and approximately 150 community based organizations to conduct any number of a variety of HIV prevention programs in the US. How do you evaluate all of that, and satisfy the needs of congressional funders, the White House, national interest groups, CDC planners, local program directors and evaluators, and the HIV prevention program client? This session will describe the approaches and challenges to national level evaluation of a wide array of HIV prevention programs and activities in order to meet the accountability, program monitoring, and program improvement needs of a number and variety of stakeholders. The three presentations will focus on the rationale, reporting and realities of conducting national HIV prevention program evaluation.
|
|
Development and Implementation of HIV Prevention Program Reporting Requirements, Tools, and Technical Assistance
|
| Marla Vaughan, Centers for Disease Control and Prevention, mhv1@cdc.gov
|
| Kimberly Thomas, Centers for Disease Control and Prevention, kit9@cdc.gov
|
| Antonya Rakestraw, Centers for Disease Control and Prevention, aip5@cdc.gov
|
| Joanna Wooster, Centers for Disease Control and Prevention, zft62cdc.gov
|
|
This presentation will discuss the collection of meaningful data at the national level through close collaboration with stakeholders and the provision of significant technical assistance to grantees. The approach of collaborating with HIV prevention partners at every stage in the development and implementation of standardized data variables and program performance indicators on a national scale is critical to the success of monitoring and evaluation efforts. Providing ongoing support to grantees as they implement the data reporting requirements is also an important part of the process. This support includes training on monitoring and evaluation and use of applications for data reporting: readily available technical assistance; development and dissemination of guidances and tools for monitoring and evaluation with a focus on local data use; and direct and extensive guidance to grantees on data reporting requirements. This approach reflects a commitment to promote greater data utilization and to demonstrate progress toward reaching our goals.
|
|
|
Data Management, Analyses, and Reporting of Large-scale National HIV Prevention Program Data
|
| John Beltrami, Centers for Disease Control and Prevention, hzb3@cdc.gov
|
| Hussain Usman, Centers for Disease Control and Prevention, gnw8@cdc.gov
|
| Nancy Habarta, Centers for Disease Control and Prevention, eqq1@cdc.gov
|
|
CDC has never before had a national system of standardized HIV prevention program data. Such data are critical for CDC to monitor and evaluate HIV prevention activities at both the local and national levels. This presentation will 1) provide a brief overview of data systems and data types, 2) describe activities related to what happens to the data once submitted by the health departments, 3) describe quality assurance (QA) reports, descriptive reports, and a QA feedback process to the health departments, 4) describe a data report and data release request system, and 5) challenges. The focus of information provided will be on the status and progress to date of this work, which began in 2008. Additionally, context will be provided that relates to a federal agency leading this national work that requires extensive collaboration and integration with multidisciplinary program and IT staff.
| |
|
HIV Prevention Program Evaluation Studies: Purpose, Process, and Predicaments
|
| Gary Uhl, Centers for Disease Control and Prevention, gau4@cdc.gov
|
| Kathleen Raleigh, Centers for Disease Control and Prevention, kmr9@cdc.gov
|
| Elizabeth Kalayil, Centers for Disease Control and Prevention, ehk2@cdc.gov
|
| Andrea Moore, Centers for Disease Control and Prevention, dii7@cdc.gov
|
|
CDC conducts focused evaluation projects to describe and examine the delivery of local and national HIV prevention programs and also outcomes such as client-level and community-level risk and behavior change. We also conduct projects to develop and disseminate guidance documents on improving the quality of local and national evaluation data. All of these projects use both qualitative and quantitative methods and a range of evaluation designs. This presentation will highlight issues relevant to evaluators such as initiating and maintaining stakeholder involvement, conducting evaluation projects in the field (as opposed to university or research settings), collecting sensitive information such as type and frequency of sexual activity from high-risk minority communities (e.g., men who have sex with men, African Americans, Hispanics), and reporting results in a variety of formats to multiple audiences.
| |